(NCT03330847) is a global, randomized phase II trial designed to assess the efficacy of combining the PARP inhibitor olaparib with DNA damage response (DDR) inhibitors (AZD6738 or AZD1775). Within this clinical framework, accurate assessment of disease burden is critical for predicting patient outcomes. While traditional staging systems like Lugano provide discrete categorization, Total Metabolic Tumor Volume (TMTV)
While a comprehensive list is difficult due to the platform's shifting catalog, three specific shoots are consistently referenced by fans: tmtv violette
In the 1960s and 1970s, the visual presentation of female broadcasters was heavily scrutinized. Oka navigated this landscape with a professional demeanor that commanded respect. In the TMTV footage, she is often seen hosting segments of Le Grand Jury or cultural roundtables. Her presence signaled a shift: women were not merely decorative "weather girls" or hosts of domestic programs; they were credible voices in the public sphere. Oka’s diction and interviewing style became a benchmark for aspiring female journalists in Montreal. (NCT03330847) is a global, randomized phase II trial